1. Introduction {#sec1-marinedrugs-17-00533}
===============

Over the last 20 years, macroalgae have ceased to be a trifle in western countries and have been considered as a nutritional and functional food, generating wealth for many coastal countries \[[@B1-marinedrugs-17-00533]\]. Red macroalgae (phylum Rhodophyta) are mainly used as a source of hydrocolloids (agar and carrageenans), generating a large turnover worldwide \[[@B2-marinedrugs-17-00533]\]. Nevertheless, the marketing of edible red macroalgae is also very important, as is the trade of Asian species of *Porphyra* sp., the most valued variety of seaweed in the world, generally recognized by its common Japanese name, nori. Recently, some of the species of the genus *Porphyra* were transferred to the genus Pyropia \[[@B3-marinedrugs-17-00533]\]. Food and agriculture organization of the united nations (FAO) data indicate that the production of *Porphyra* sp. is global, but Japan, China, and the Republic of Korea are still the main producers \[[@B4-marinedrugs-17-00533]\]. From 2000 to 2016, the Global Aquaculture Production for *Porphyra* sp. increased from 424,913 to 1,352,520 tons, demonstrating the enormous demand for these edible red seaweeds \[[@B4-marinedrugs-17-00533]\]. Nonetheless, there is another valuable red macroalga that has remained largely overlooked, *Palmaria palmata* ((Linnaeus) F. Weber & D. Mohr, 1805), also known as dulse (Palmariales, Rhodophyta). It is an edible red macroalga found in the coastal waters of the North Atlantic \[[@B5-marinedrugs-17-00533]\]. Its lipid content, as in most macroalgae, compared to other photosynthetic lipid sources is considered low (0.3--3.8% of dry weight) and erroneously devalued \[[@B6-marinedrugs-17-00533]\]. However, the lipids of *P. palmata* are easily assimilated by the human body and have a high content of eicosapentaenoic acid (EPA), a golden fatty acid (FA) in healthy diets and important in the prevention of non-communicable diseases (NCDs), which are responsible for the deaths of 41 million people each year (equivalent to 71% of all deaths worldwide) \[[@B7-marinedrugs-17-00533],[@B8-marinedrugs-17-00533]\]. Eicosapentaenoic acid is an omega-3 (*n*-3) polyunsaturated fatty acid(PUFA) that plays an effective role in the improvement and prevention of cardiovascular and neurodegenerative diseases, as well as beneficial antioxidant and anti-inflammatory effects \[[@B9-marinedrugs-17-00533],[@B10-marinedrugs-17-00533],[@B11-marinedrugs-17-00533]\]. The PUFA of seaweeds are generally located in the structural lipids found in their membranes in the form of phospholipids (PLs) and glycolipids (GLs). To our best knowledge, the polar lipids of *Palmaria palmata* have not been studied so far, and the lack of knowledge on this subject must be overcome because polar lipids bearing EPA have recently been associated with several bioactive properties, such as antitumor \[[@B12-marinedrugs-17-00533],[@B13-marinedrugs-17-00533]\], anti-inflammatory \[[@B14-marinedrugs-17-00533],[@B15-marinedrugs-17-00533]\], antimicrobial \[[@B16-marinedrugs-17-00533],[@B17-marinedrugs-17-00533]\], and antiviral \[[@B18-marinedrugs-17-00533]\]. Thus, the identification of the *P. palmata* lipidome is crucial for future exploitation and valorization. In addition, seaweed lipids are also recognized as natural and organic antioxidants with different applications \[[@B19-marinedrugs-17-00533]\]. Today, there is an increasing demand for new antioxidants for the food, feed, nutraceuticals, and cosmetic industry, and consequently, an increasing bioprospecting effort. Food containing phytochemical antioxidants can be used as nutritional supplements and functional foods and to extend the shelf life of food for human consumption. In addition, the cosmetic industry is increasingly looking for natural antioxidants recognized as active ingredients for cosmetic formulations that alter the effects of ageing and act as inhibitors of oxidants \[[@B20-marinedrugs-17-00533]\]. Nevertheless, to our best knowledge, the lipid antioxidant potential of *P. palmata* has not yet been explored.

Knowing the lipid profile of macroalgae can help to reveal their healthy attributes and their added value. The use of lipidomics approaches based on liquid chromatography mass spectrometry (LC-MS) has been successfully used for this purpose \[[@B21-marinedrugs-17-00533],[@B22-marinedrugs-17-00533],[@B23-marinedrugs-17-00533],[@B24-marinedrugs-17-00533],[@B25-marinedrugs-17-00533]\] but has not yet been applied to the profiling of *P. palmata*. The present study characterized the polar lipid signature of *P. palmata* farmed in an integrated multi-trophic aquaculture (IMTA) system. A lipidomic approach based on LC-MS was used to detect lipids bearing *n*-3 fatty acids. Also, the antioxidant activity of the polar lipid-rich extract was also screened, through the free radical scavenging potential against α,α-diphenyl-β-picrylhydrazyl (DPPH) and 2,20-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) radicals. Our goal was to add value to *P. palmata* by presenting it as a bioactive lipid source and EPA carrier with potential applications in the fields of food, feed, pharma, and cosmetics.

2. Results {#sec2-marinedrugs-17-00533}
==========

2.1. Identification of the of Palmaria Palmata Lipidome {#sec2dot1-marinedrugs-17-00533}
-------------------------------------------------------

The lipid extracts of *P. palmata* represented an average yield of 1% by dry weight (255.6 ± 1.19 mg of biomass, 2.58 ± 0.19 mg lipid extract). The fatty acid composition of the lipid extract of *P. palmata*, identified by gas chromatography-mass spectrometry (GC-MS) ([Table 1](#marinedrugs-17-00533-t001){ref-type="table"}), shows the prevalence of 20:5(*n*-3) EPA with a relative abundance of 51.68% ± 6.5. The saturated FA 16:0, 18:0, and 14:0 represented 24.32% ± 1.11, 12.45% ± 6.74, and 5.32 ± 0.44, respectively. The others FA identified had relative abundances of less than 5%. The GC-MS analysis also identified phytol compounds, a component of chlorophyll and vitamin E and K. Phytol is a precursor of vitamin E, an important nutritional supplement obtained commercially by isolation from natural sources \[[@B26-marinedrugs-17-00533]\].

Identification of the polar lipid profile at the molecular level was performed by high-resolution hydrophilic interaction liquid chromatography-mass spectrometry - HILIC-LC-MS and HILIC-LC-MS/MS. In total, 46 molecular species of glycolipids were identified, 1 molecular species of betaine lipids, 91 molecular species of phospholipids, and 6 molecular species of inositephosphoceramide lipids, representing a total of 144 species of lipids. The glycolipids identified included the acidic glycolipids sulfoquinovosyl diacylglycerol (SQDG) ([Figure 1](#marinedrugs-17-00533-f001){ref-type="fig"}) and sulfoquinovosyl monoacylglycerol (SQMG) classes, assigned as \[M − H\]^−^ ions in the LC-MS spectra ([Table 2](#marinedrugs-17-00533-t002){ref-type="table"}) and the neutral glycolipids monogalactosyldiacylglycerol (MGDG), monogalactosylmonoacylglycerol (MGMG), digalactosyldiacylglycerol (DGDG) ([Figure 2](#marinedrugs-17-00533-f002){ref-type="fig"}) plus digalactosylmonoacylglycerol (DGMG) classes, identified in the positive LC-MS spectra as \[M + NH~4~\]^+^ ions ([Table 3](#marinedrugs-17-00533-t003){ref-type="table"}). The most abundant species in each class of glycolipids was assigned as SQDG (36:5) corresponding to SQDG (20:5/16:0), SQMG (14:0), DGDG (36:5) as DGDG (20:5/16:0), DGMG(16:0), MGDG (40:10) as MGDG (20:5/20:5), and MGMG (20:5).

Betaine lipids of *P. palmata* included only one species of diacylglyceroltrimethylhomoserine (DGTS) assigned as DGTS (32:5), with a molecular formula of C~42~H~80~O~7~N, and identified in the LC-MS spectra as positive \[M + H\]^+^ ions. Its theoretical *m/z* is 710.5935 and the observed *m/z* was 710.5936 (0.14 ppm).

The classes of phospholipids found in *P. palmata* included phosphatidylcholine (PC) ([Figure 3](#marinedrugs-17-00533-f003){ref-type="fig"}A), lyso-PC (LPC), phosphatilylethanolanime (PE) ([Figure 3](#marinedrugs-17-00533-f003){ref-type="fig"}B), and lyso-PE (LPE) were identified in the LC-MS spectra as positive \[M + H\]^+^ ions ([Table 4](#marinedrugs-17-00533-t004){ref-type="table"}). Phosphatidylglycerol (PG) ([Figure 4](#marinedrugs-17-00533-f004){ref-type="fig"}), lyso-PG (LPG), phosphatidylinositol (PI), and phosphatidic acid (PA) were identified in the LC-MS spectra as negative \[M − H\]^−^ ions ([Table 5](#marinedrugs-17-00533-t005){ref-type="table"}). Also, inositephosphoceramide lipids (IPC) were identified as negative \[M + CH~3~COO\]^−^ ions ([Table 6](#marinedrugs-17-00533-t006){ref-type="table"}). The PC(40:10) identified as PC(20:5/20:5), LPC(20:5), PE(40:10) identified as PE(20:5/20:5), LPE(20:5), PG(36:6) as PG(16:1/20:5), LPG(14:0), PI(40:10) as PI(20:5/20:5), PA(40:10) as PA(20:5/20:5), and PI-Cer(d40:2) represent the most abundant species within each phospholipid class.

The relative quantification of the identified species was calculated after integrating the peak area of each identified ion, normalized to the internal standard and divided by the sum of the normalized area of all species. Lipid species identified with a relative percentage of 0.5% or greater are shown in [Figure 5](#marinedrugs-17-00533-f005){ref-type="fig"}. Phospholipids were the group of lipids with the largest number of species (91 species). Particular emphasis is placed on PC(40:10), assigned as PC(20:5/20:5), which was the most abundant identified lipid species, with an average relative percentage of 23.7%. The PC(36:5), assigned as PC(16:0/20:5) was the second most abundant species, with an average relative percentage of 10.4%. It remains important to highlight the lipid species SQDG(36:5), MGDG(40:10), DGDG(36:5), SQDG(30:0), and MGMG(20:5), with an average relative percentage of 5% or greater. Both PC species are EPA carriers. The 20:5 fatty acyl chain was confirmed by LC-MS/MS spectra data analysis of the above-mentioned species, with the exception of SQDG (30:0). Indeed, the lipid molecular species with 5 and 10 double bonds on the fatty acid acyl chains are clearly pronounced ([Figure 6](#marinedrugs-17-00533-f006){ref-type="fig"}), corroborating the prevalence of EPA.

2.2. Evaluation of Antioxidant Activity {#sec2dot2-marinedrugs-17-00533}
---------------------------------------

The antioxidant potential of *P. palmata* polar lipid-rich extract was evaluated through free radical DPPH^●^ and ABTS^●+^ scavenging assays. While DPPH assay measures the ability of antioxidants to scavenge the DPPH^●^ generated in the organic phase, the ABTS^●+^ assay acts in the same way in the aqueous phase. The percentage of radical inhibition in the presence of extracts rich in polar lipids was calculated after 120 minutes. The percent inhibition is proportional to time and the lipid extract concentration, even though the response appeared to be non-linear, with better performance for the ABTS^●+^ assay ([Figure 7](#marinedrugs-17-00533-f007){ref-type="fig"}).

Results gathered in these assays showed that for the DPPH assay, the polar lipid-rich extract concentration providing 30% of inhibition (IC30) was 171 ± 19.8 µg/mL with a TE of 88.7 ± 7.7 Trolox µmol/g lipid. The polar lipid-rich extract concentration providing 50% inhibition (IC50) in the ABTS assay was 26.2 ± 0.1 µg/mL with a TE of 555.4 ± 28.1 Trolox µmol/g lipid. The reactivity and the capacity of the extract rich in polar lipids to scavenge these radical were very different. While for the ABTS assay it was possible to calculate 50% inhibition, in the case of the DPPH assay, the maximum percentage of inhibition reached nearly 30%.

3. Discussion {#sec3-marinedrugs-17-00533}
=============

The consumption of long-chain PUFA, particularly *n*-3, may have long-term health benefits. Their positive effects include reduced cardiovascular disease, morbidity, and mortality \[[@B30-marinedrugs-17-00533],[@B31-marinedrugs-17-00533],[@B32-marinedrugs-17-00533]\]; enhanced visual and neurological development; and improved of inflammatory conditions, such as arthritis and asthma \[[@B33-marinedrugs-17-00533],[@B34-marinedrugs-17-00533],[@B35-marinedrugs-17-00533]\]. It is recognized that seafood is the main source of *n*-3 long-chain PUFAs, mainly EPA and docosahexaenoic acid (DHA). However, global overexploitation and depletion of marine fish stocks is of long-standing concern, as existing populations of wild and farmed species are unlikely sufficient to meet *n*-3 PUFA requirements for human consumption. In this context, *P. palmata* appears as an interesting source of EPA that can be supplied in a socio-ecologically sustainable way. Namely its production in IMTA systems compared to current wild harvesting practices might ensure the availability of biomass with increased stability of its nutritional value and biochemical profile, namely its polar lipids and its PUFA composition \[[@B36-marinedrugs-17-00533],[@B37-marinedrugs-17-00533]\].

As described above ([Table 1](#marinedrugs-17-00533-t001){ref-type="table"}, [Table 2](#marinedrugs-17-00533-t002){ref-type="table"}, [Table 3](#marinedrugs-17-00533-t003){ref-type="table"} and [Table 4](#marinedrugs-17-00533-t004){ref-type="table"}), PL and GL of *P. palmata* are quite rich in EPA. Our work is consistent with previous studies that reported high levels of EPA in *P. palmata* compared to other edible seaweeds \[[@B8-marinedrugs-17-00533],[@B38-marinedrugs-17-00533]\].

Phospholipids, in particular those rich in PUFA (namely EPA), contribute significantly to the added value of *P. palmata*. There is evidence that PLs are better delivers of PUFA than triglycerides (TGs) \[[@B39-marinedrugs-17-00533],[@B40-marinedrugs-17-00533]\]. Several studies suggested that much of the dietary PLs fraction is integrated into high-density lipoprotein (HDL) in the intestine, later joining the plasma HDL pool \[[@B41-marinedrugs-17-00533],[@B42-marinedrugs-17-00533],[@B43-marinedrugs-17-00533]\]. Since PLs are associated with low toxicity, allowing their use for any route of administration, PL from *P. palmata* are potential candidates for food and nutraceutical formulations.

Phosphatidylcholine is the most abundant phospholipid class of *P. palmata*. Administration of PCs has been reported to be beneficial for senescence, cognitive function, inflammatory diseases, and plasma and hepatic lipid metabolism \[[@B44-marinedrugs-17-00533],[@B45-marinedrugs-17-00533],[@B46-marinedrugs-17-00533],[@B47-marinedrugs-17-00533]\]. It can also be used as a choline supplier. Choline is a component of the vitamin B complex, essential for human nutrition and used by the body to produce acetylcholine, one of the major neurotransmitters of the nervous system, involved in neural networks associated with memory \[[@B48-marinedrugs-17-00533]\]. Choline supplementation is important for vegans and vegetarians, who are at a higher risk for choline deficiency. Some studies also linked high choline intake with reduced risk of breast and colorectal cancer \[[@B49-marinedrugs-17-00533],[@B50-marinedrugs-17-00533],[@B51-marinedrugs-17-00533]\]. Thus *P. palmata* PLs could be considered as a potential functional food or as an ingredient for the fortification of foods for nutraceutical applications.

Other potential uses of *P. palmata* PLs are either in the cosmetics or in the pharma industries. Cosmetic formulations use the emulsifying properties of PLs for skin moisturizing products \[[@B52-marinedrugs-17-00533]\]. Pharmaceutical applications of PLs rely on their ability to form liposomes after mixing in aqueous media, making them a potential drug delivery vector \[[@B52-marinedrugs-17-00533],[@B53-marinedrugs-17-00533]\]. Therefore, *P. palmata* PLs can potentially be used as emulsifiers, as an *n*-3 FAs supplement, and as beneficial nutritional biomolecules. Macroalgae are also considered a promising source of value-added phytochemicals. Several studies have reported that glycolipids can also display bioactive activities, including antioxidant \[[@B54-marinedrugs-17-00533]\], anti-inflammatory \[[@B14-marinedrugs-17-00533]\], anti-proliferative \[[@B55-marinedrugs-17-00533]\], and anti-microbial \[[@B56-marinedrugs-17-00533]\] activities. Some of the glycolipids identified in *P. palmata* have already been described as having bioactive properties, such as SQDG(34:2) with antiviral activity against HCM-virus \[[@B16-marinedrugs-17-00533]\], SQMD(16:0) with antibacterial activity against *Xanthomonas oryzae* \[[@B57-marinedrugs-17-00533]\], and the SQDG carrier of EPA with anti-proliferative effect on the inhibition of human telomerase \[[@B12-marinedrugs-17-00533]\] and DNA polymerase α and β \[[@B58-marinedrugs-17-00533]\]. Additionally, a study by Banskota and collaborators \[[@B14-marinedrugs-17-00533]\] attributed the anti-inflammatory action of *P. palmata* to polar lipids, including SQDG(20:5;14:0), via the inhibitory activity of nitric oxide, highlighting the role of EPA. Moreover, a MGDG carrier of EPA was patented because of its anti-inflammatory action \[[@B59-marinedrugs-17-00533]\]. The search for natural antioxidants has long attracted the attention of researchers, since inflammation is associated with oxidative stress occurring in several diseases, including chronic and age-related ones \[[@B60-marinedrugs-17-00533],[@B61-marinedrugs-17-00533]\]. Oxidative stress occurs when the production of radicals increases and exceeds the detoxification capacity of cellular antioxidant defense systems. Antioxidants are biomolecules that prevent, or delay damage to other molecules, by the presence of free radicals, because they have the ability to block or inhibit them directly or indirectly, or because they stimulate cellular antioxidant defenses \[[@B62-marinedrugs-17-00533]\]. Antioxidants from natural or organic sources aim not only to promote the development of new drugs but also to act in the prevention of inflammatory diseases \[[@B63-marinedrugs-17-00533]\]. Such biomolecules with antioxidant properties can be obtained from foods, including plants and marine vegetables \[[@B64-marinedrugs-17-00533],[@B65-marinedrugs-17-00533]\]. There are some studies of seaweed lipid characterization using lipidomics based on the LC-MS approach that allowed the putative bioactivity and health benefits of seaweeds lipids to be highlighted, as well the exploitation of seaweeds as a functional food, as reported for *Codium tomentosum*, *Porphyra dioica*, *Gracilaria* sp, *Chondrus crispus*, *Ulva rigida*, *Saccharina latissima*, and *Fucus vesiculosus* \[[@B21-marinedrugs-17-00533],[@B22-marinedrugs-17-00533],[@B23-marinedrugs-17-00533],[@B24-marinedrugs-17-00533],[@B25-marinedrugs-17-00533],[@B66-marinedrugs-17-00533],[@B67-marinedrugs-17-00533]\]. However, seaweeds' lipids antioxidant potential was not explored.

The antioxidant activity of seaweeds has been mostly related to their phenolic compounds and pigment contents \[[@B68-marinedrugs-17-00533],[@B69-marinedrugs-17-00533],[@B70-marinedrugs-17-00533],[@B71-marinedrugs-17-00533],[@B72-marinedrugs-17-00533]\], whereas it is only now that lipids are beginning to deserve special attention. To the best of our knowledge, there is only one study of lipids' fraction antioxidant activity for the red and brown seaweeds *Solieria chordalis* ((C.Agardh) J. Agardh, 1842) and *Sargassum muticum* ((Yendo) Fensholt, 1955), respectively, whose antioxidant potential was lower than the one obtained in this study for *P. palmata* \[[@B19-marinedrugs-17-00533]\]. Overall, our results showed that the polar lipid-rich extract of *P. palmata* exhibits antioxidant proprieties, showing a higher percentage inhibition of DPPH and TE than those of the methanolic extract *of P. palmata*, mainly composed of phenolic compounds, as previously described \[[@B68-marinedrugs-17-00533]\]. It also showed significantly better antioxidant activity for the DPPH^●^ and ABTS^●+^ assays compared to the red seaweed *Gracilaria manilaensis* (Yamamoto & Trono, 1994) organic extract \[[@B73-marinedrugs-17-00533]\]. The polar lipid-rich extract of *P. palmata* still had a higher antioxidant potential for the ABTS^●+^ assay compared to a study of antioxidant activity using different organic solvents with phenolic content from the brown seaweed *Sargassum serratifolium* ((C. Agardh) C. Agardh, 1820) \[[@B74-marinedrugs-17-00533]\].

4. Materials and Methods {#sec4-marinedrugs-17-00533}
========================

4.1. Reagents {#sec4dot1-marinedrugs-17-00533}
-------------

Phospholipid standards 1,2-dimyristoyl-*sn*-glycero-3-phosphocholine (dMPC), 1,2-dimyristoyl-*sn*-glycero-3-phosphoethanolamine (dMPE), 1,2-dimyristoyl-*sn*-glycero-3-phospho-(1′-rac-)glycerol (dMPG), 1,2-dimyristoyl-*sn*-glycero-3-phospho-L-serine (dMPS), 1′,3′-bis\[1--dimyristoyl-*sn*-glycero-3-phospho\]-glycerol (tMCL), 1,2-dipalmitoyl-*sn*-glycero-3-phosphatidylinositol (dPPI), *N*-palmitoyl-D-erythro-sphingosylphosphorylcholine (NPSM), and 1-nonadecanoyl-2-hydroxy-*sn*-glycero-3-phosphocholine (LPC) were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL). Chloroform (CHCl~3~), methanol (MeOH), ethanol absolute, and acetonitrile were purchased from Fisher scientific (Leicestershire, UK); all the solvents were of high-performance liquid chromatography (HPLC) grade and were used without further purification. DPPH^●^ was purchased from Aldrich (Milwaukee, WI). 2,20-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS^●+^) was obtained from Fluka (Buchs, Switzerland). Ammonium acetate and 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox) were purchased from Sigma-Aldrich (St Louis, MO, USA). All the other reagents and chemicals used were of the highest grade of purity commercially available. Milli-Q water was also used (Synergysup^®^, Millipore Corporation, Billerica, MA, USA).

4.2. Seaweed Biomass {#sec4dot2-marinedrugs-17-00533}
--------------------

The biomass *of Palmaria palmata* ((Linnaeus) F.Weber & D.Mohr, 1805) was provided by a local aquaculture producer-ALGAplus-who farms seaweed integrated with finfish production (located at Ria de Aveiro coastal lagoon, mainland Portugal, 40°36′43″N, 8°40′43″W). *Palmaria palmata* is produced by vegetative propagation, in a controlled indoor system from June to September (approximately) and in an open-flow outdoor tank system during colder months. For this work, the red algae were harvested in May 2018, cleaned to remove the epiphytes, and washed using sterilized seawater. It was then dried at 25 °C in an air tunnel until 10% to 12% total moisture was reached. Five 250-mg aliquots were obtained from bulk production and were used for total lipid extraction.

4.3. Lipid Extraction {#sec4dot3-marinedrugs-17-00533}
---------------------

The biomass of *P. palmata* was cut into small pieces and ground in a mortar and pestle with liquid nitrogen until homogenized. The lipid extraction procedure was performed using a modified Bligh and Dyer protocol \[[@B23-marinedrugs-17-00533]\], mixing 250 mg of seaweed biomass (five replicates) with 2.5 mL of MeOH and 1.25 mL of CHCl~3~ in a glass PYREX tube and homogenized by vortexing for 2 min and incubation in ice on a rocking platform shaker (Stuart equipment, Bibby Scientific, Stone, UK) for 2 h and 30 min. The mixture was centrifuged (Selecta JP Mixtasel, Abrera, Barcelona, Spain) for 10 min at 2000 rpm and the organic phase was collected in a new glass tube. The biomass residue was re-extracted twice with 2 mL of MeOH and 1 mL of CHCl~3~. To wash the lipid extract and induce phase separation, 2.3 mL of Milli-Q water was added to the final organic phase, followed by centrifugation for 10 min at 2000 rpm. The organic lower phase was collected in a new glass tube and dried under a nitrogen stream. Lipid extracts were then transferred to amber vials, dried again, weighed, and stored at −20 °C. Lipid content was estimated as a dry weight percentage.

4.4. Fatty Acid Analysis by Gas Chromatography Mass Spectrometry {#sec4dot4-marinedrugs-17-00533}
----------------------------------------------------------------

Fatty acid methyl esters (FAMEs) were prepared using a methanolic solution of potassium hydroxide (2.0 M) (Melo et al., 2015). A sample volume of 2 μL of hexane solution containing FAMEs was analyzed by gas chromatography mass spectrometry (GC-MS) on a GC system (Agilent Technologies 6890 N Network, Santa Clara, CA, USA) equipped with a DB-FFAP column with the following specifications: 30 m long, 0.32 mm internal diameter, and 0.25 μm film thickness (123--3232, J & W Scientific, Folsom, CA, USA). The GC equipment was connected to an Agilent 5973 Network Mass Selective Detector operating with an electron impact mode at 70 eV and scanning range *m/z* of 50 to 550 in a one second cycle in full scan mode acquisition. The oven temperature was programmed from an initial temperature of 80 °C for 3 min, a linear increase to 160 °C at 25 °C min^−1^, followed by linear increase at 2 °C min^−1^ to 210 °C, then at 30 °C min^−1^ to 250 °C, standing at 250 °C for 10 min. The injector and detector temperatures were 220 and 280 °C, respectively. Helium was used as the carrier gas at a flow rate of 1.4 mL min^−1^. FA identification was performed considering the retention times and MS spectra of FA standards (Supelco 37 Component Fame Mix, Sigma-Aldrich), and by MS spectrum comparison with chemical databases (Wiley 275 library and AOCS lipid library). FAMEs of five analytical replicates were injected. The relative amounts of FAs were calculated by the percent relative area method with proper normalization using internal standard methyl nonadecanoate (C19:0, Sigma-Aldrich, St. Louis, MO, USA), considering the sum of all relative areas of identified FAs.

4.5. Polar Lipid Analysis by Hydrophilic Interaction Liquid Chromatography Mass Spectrometry (HILIC-ESI-MS) {#sec4dot5-marinedrugs-17-00533}
-----------------------------------------------------------------------------------------------------------

Lipid extracts were analyzed by mass spectrometry using hydrophilic interaction liquid chromatography (HILIC) on an Ultimate 3000 Dionex (Thermo Fisher Scientific, Bremen, Germany) with an autosampler coupled to a Q-Exactive hybrid quadrupole mass spectrometer (Thermo Fisher, Scientific, Bremen, Germany). The elution method was previously described \[[@B21-marinedrugs-17-00533],[@B24-marinedrugs-17-00533],[@B25-marinedrugs-17-00533]\] and applied with some modifications. The system is based on two mobile phases: Mobile phase A (25% water, 50% acetonitrile, and 25% methanol) and mobile phase B (60% acetonitrile and 40% methanol), both with 1 mM ammonium acetate. Firstly, 40% of mobile phase A was held isocratically for 8 min, followed by a linear increase to 60% of mobile phase A within 7 min, and maintained for 5 minutes. After that, conditions returned to the initial settings in 15 minutes (5 min to decrease to 40% of phase A and a re-equilibration period of 10 min prior to the next injection). A volume of 5 µL of each sample, containing 5 µg of lipid extract in CHCl~3~, 4 µL of phospholipid standards mix (dMPC-0.02 µg, dMPE-0.02 µg, LPC-0.02 µg, dPPI-0.08 µg, dMPG-0.012 µg, dMPS-0.04 µg, NPSM-0.02 µg, dMPA-0.08 µg, tMCL-0.08 µg), and 91 µL of starting eluent (60% B and 40% A), was introduced into the Ascentis Si column HPLC Pore column (15 cm × 1 mm, 3 µm, Sigma-Aldrich) with a flow rate of 40 µL min^−1^ at 30 °C. The mass spectrometer with Orbitrap^®^ technology was operated in simultaneous positive (electrospray voltage 3.0 kV) and negative (electrospray voltage ‒2.7 kV) modes with high resolution with 70,000 and AGC target of 1 × 10^6^, the capillary temperature was 250 °C, and the sheath gas flow was 15 U. The tandem mass spectrometry experiments were performed at a resolution of 17,500 and AGC target of 1 × 10^5^ with one full scan mass spectrum and 10 data-dependent MS/MS scans. The cycles were repeated continuously throughout the experiments with the dynamic exclusion of 60 s and an intensity threshold of 1 × 10^4^. Normalized collision energy™ (CE) ranged between 25, 30, and 35 eV. Data acquisition was performed using the Xcalibur data system (V3.3, Thermo Fisher Scientific, USA). The identification of molecular species of polar lipids was based on the assignment of the molecular ions observed in the LC-MS spectra, typical retention time, mass accuracy, and MS/MS spectra information.

4.6. Data Analysis {#sec4dot6-marinedrugs-17-00533}
------------------

In a first approach, the lipid species of *P. palmata* were identified using MZmine 2.32 software. This tool allows the analysis of raw data acquired in full MS by the integration of each lipid species peak, peak processing, and assignment against an in-house database. The validated peaks were within the time range of a MS full run and peaks with raw intensity lower than 1e4 were excluded. All the information originating from the MZmine software was confirmed based on the assignment of the molecular ions observed in the LC-MS spectra, typical retention time, exact mass accuracy, and MS/MS spectra information. Only exact mass accuracy with an error of less than 5 ppm was considered. The typical fragmentation of each lipid class in MS/MS spectra was taken into account according to what has already been described in the literature \[[@B25-marinedrugs-17-00533]\]. The normalization of the identified lipid species was performed by exporting integrated peak areas values (.csv file) and dividing the peak area value of each species by the peak area value of a standard lipid species with the closest retention time. The lipid species' relative abundance was calculated in terms of the percentage dividing the normalized value of each lipid species by the sum of all identified lipid species. Bar graphs were created using the software GraphPad Prism 8.0.1

4.7. 2-Diphenyl-1-Picrylhydrazyl Radical Assay---DPPH Radical Scavenging Activity {#sec4dot7-marinedrugs-17-00533}
---------------------------------------------------------------------------------

The antioxidant scavenging activity against the α,α-diphenyl-β-picrylhydrazyl radical (DPPH^●^) was evaluated using a previously described method \[[@B75-marinedrugs-17-00533],[@B76-marinedrugs-17-00533]\] applied with some modifications. A stock solution of DPPH^●^ in ethanol (250 μmol/L) was prepared and diluted to provide a working solution with an absorbance value of \~0.9 measured at 517 nm using a UV-vis spectrophotometer (Multiskan GO 1.00.38, Thermo Scientific, Hudson, NH, USA) controlled by the SkanIT software version 3.2 (Thermo Scientific). To evaluate the radical stability, a volume of 150 μL of ethanol was added to 15 microplate wells followed by addition of 150 μL of DPPH^●^ diluted solution and an incubation period of 120 minutes, with absorbance measured at 517 nm every 5 minutes. For evaluation of the radical scavenging potential, a volume of 150 μL of *P. palmata* lipid extract (25, 50, 100, 250 μg/mL in ethanol) and 150 μL of Trolox standard solution (5, 12.5, 25, 37.5 μmol/L in ethanol) were placed in each well followed by addition of 150 μL of DPPH^●^ diluted solution, and again an incubation period of 120 minutes, with absorbance measured at 517 nm every 5 minutes. The control lipid extracts were also assayed by replacing 150 μL of DPPH^●^ diluted solution by 150 μL of ethanol. Radical reduction by hydrogen donor antioxidants was monitored by measuring the decrease in absorbance during the reaction, thereby quantifying radical scavenging, which is accompanied by a radical color change. All measurements were performed in triplicate on two different days. The % of DPPH radical remaining was determined according to:

The free radical-scavenging activity of samples was determined as the percentage of inhibition of DPPH radical according to:

The concentration of samples capable of reducing 30% of DPPH radical after 120 minutes (IC30) were calculated by linear regression using the concentration of samples and the percentage of the inhibition curve. The activity is expressed as Trolox Equivalents (TE, μmol Trolox/g of sample), according to:

4.8. 2,20-Azino-bis-3-Ethylbenzothiazoline-6-Sulfonic Acid Radical Cation Assay---ABTS Radical Scavenging Activity {#sec4dot8-marinedrugs-17-00533}
------------------------------------------------------------------------------------------------------------------

The antioxidant scavenging activity against the 2,20-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid radical cation (ABTS^●+^) was evaluated using a previously described method \[[@B76-marinedrugs-17-00533],[@B77-marinedrugs-17-00533]\] applied with some modifications. The ABTS radical solution (3.5 mmol/L) was prepared by mixing 10 mL of ABTS stock solution (7 mmol/L in water) with 10 mL of potassium persulfate K~2~S~2~O~8~ (2.45 mmol/L in water) \[[@B77-marinedrugs-17-00533],[@B78-marinedrugs-17-00533]\]. This mixture was kept for 12 h at room temperature and was diluted in ethanol to obtain an absorbance value of \~0.9 measured at 734 nm using a UV-vis spectrophotometer (Multiskan GO 1.00.38, Thermo Scientific, Hudson, NH, USA) controlled by the SkanIT software version 3.2 (Thermo Scientific). For an evaluation of the radical stability, a volume of 150 μL of ethanol was added to 15 microplate wells followed by addition of 150 μL of ABTS^●+^ diluted solution and an incubation period of 120 minutes, with absorbance measured at 734 nm every 5 minutes. For an evaluation of the radical scavenging potential, a volume of 150 μL of lipid extract (25, 50, 100, 250 μg/mL in ethanol) and 150 μL of Trolox standard solution (4, 8, 16, 28, 40, 56 μmol/L in ethanol) were placed in each well followed by addition of 150 μL of ABTS^●+^ diluted solution, and a new incubation period of 120 minutes, with absorbance measurements at 734 nm every 5 minutes. The control lipid extracts were also assayed by replacing 150 μL of ABTS^●+^ diluted solution by 150 μL of ethanol. Radical reduction by hydrogen donor antioxidants was monitored by measuring the decrease in absorbance during the reaction, thereby quantifying radical scavenging, which is accompanied by a radical color change. All measurements were performed in triplicate on two different days. The % of ABTS radical remaining was determined according to:

The free radical-scavenging activity of samples was determined as the percentage of inhibition of ABTS radical according to:

The concentration of samples capable of reducing 30% of ABTS radical after 120 minutes (IC50) were calculated by linear regression using the concentration of samples and the percentage of the inhibition curve. The activity is expressed as Trolox Equivalents (TE, μmol Trolox/g of sample), according to:

5. Conclusions {#sec5-marinedrugs-17-00533}
==============

In this study, the use of a mass spectrometry-based approach identified 144 lipid species of *P. palmata* produced in an environmentally friendly IMTA system. Eicosapentaenoic acid was the most abundant fatty acid identified in *P. palmata*, with a relative abundance greater than 50%. The content of EPA may be one of the major factors in the antioxidant activity of the polar lipid-rich extract, which has been found to be superior to that of phenolic compounds described in previous studies. Nevertheless, our results may not be exclusive to lipids, and synergy with other molecules should be taken into account. These findings revealed the lipid profile of *P. palmata* and highlighted that when farmed under IMTA, *P. palmata* can be a stable and sustainable source of beneficial lipids. The findings reported in this study add value to the polar lipid-rich extract of *P. palmata* and open a window of opportunity for innovative biotechnological applications targeting algal-based products. This work is the beginning of polar lipid prospection in *P. palmata* biomass and its results should now be validated across other possible *P. palmata* sources.
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![Percent inhibition as a function of the concentration of the lipid extract after 120 minutes of DPPH^●^ (**A**) and ABTS^●+^ (**B**) radical scavenging activity.](marinedrugs-17-00533-g007){#marinedrugs-17-00533-f007}

marinedrugs-17-00533-t001_Table 1

###### 

Fatty acid profile of *P. palmata* determined by GC-MS analysis. Abundances are expressed in relative abundance (%). Values are averages of five samples ± standard deviation. Double bond position of 18:1 and 18:2 was not identified.

  Fatty Acid    Relative Abundance (%) ± SD
  ------------- -----------------------------
  14:0          5.32 ± 0.44
  16:0          24.32 ± 1.11
  16:1(*n*-7)   2.03 ± 0.43
  18:0          12.45 ± 6.74
  18:1          2.82 ± 0.54
  18:2          0.45 ± 0.19
  20:4(*n*-6)   0.92 ± 0.17
  20:5(*n*-3)   51.68 ± 6.47

marinedrugs-17-00533-t002_Table 2

###### 

Molecular species of glycolipids SQDGs and SQMGs identified by HILIC-ESI-MS as \[M − H\]^−^ ions. C represents the total number of carbon atoms and N represents the total number of double bonds on the fatty acyl chains. The most abundant species in each class are highlighted in bold type. Fatty acids' *sn*-1 and *sn*-2 position is based on biosynthetic pathways \[[@B27-marinedrugs-17-00533],[@B28-marinedrugs-17-00533],[@B29-marinedrugs-17-00533]\].

  -----------------------------------------------------------------------------------------------------------------------
  Theoretical *m/z*   Observed\      Error (ppm)   Lipid Species (C:N)   Fatty Acyl Chains         Formula
                      *m/z*                                                                        
  ------------------- -------------- ------------- --------------------- ------------------------- ----------------------
  **527.2526**        **527.2541**   **2.84**      **SQMG(14:0)**        **14:0**                  **C~23~H~43~O~11~S**

  555.2839            555.2855       2.88          SQMG(16:0)            16:0                      C~25~H~47~O~11~S

  737.4510            737.4529       2.58          SQDG(28:0)            14:0/14:0                 C~37~H~69~O~12~S

  763.4666            763.4685       2.49          SQDG(30:1)            14:0/16:1                 C~39~H~71~O~12~S

  765.4823            765.4797       −3.40         SQDG(30:0)            14:0/16:0                 C~39~H~73~O~12~S

  785.4510            785.4531       2.67          SQDG(32:4)            16:3/16:1                 C~41~H~69~O~12~S

  787.4666            787.4630       −4.57         SQDG(32:3)            16:3/16:0                 C~41~H~71~O~12~S

  789.4823            789.4861       4.81          SQDG(32:2)            18:2/14:0                 C~41~H~73~O~12~S

  791.4979            791.5001       2.78          SQDG(32:1)            18:1/14:0                 C~41~H~75~O~12~S

  793.5136            793.5156       2.52          SQDG(32:0)            16:0/16:0                 C~41~H~77~O~12~S

  811.4666            811.4685       2.34          SQDG(34:5)            20:5/14:0                 C~43~H~71~O~12~S

  819.5292            819.5308       1.95          SQDG(34:1)            20:1/14:0                 C~43~H~79~O~12~S

  821.5449            821.5461       1.46          SQDG(34:0)            \*                        C~43~H~81~O~12~S

  837.4823            837.4834       1.31          SQDG(36:6)            20:5/16:1                 C~45~H~73~O~12~S

  **839.4979**        **839.4998**   **2.26**      **SQDG(36:5)**        **20:5/16:0**             **C~45~H~75~O~12~S**

  847.5605            847.5618       1.53          SQDG(36:1)            20:1/16:0                 C~45~H~83~O~12~S

  859.4666            859.4682       1.86          SQDG(38:9)            22:5/16:4 and 20:5/18:4   C~47~H~71~O~12~S

  875.5918            875.5939       2.40          SQDG(38:1)            24:1/14:0                 C~47~H~87~O~12~S

  885.4823            885.4843       2.26          SQDG(40:10)           20:5/20:5                 C~49~H~73~O~12~S
  -----------------------------------------------------------------------------------------------------------------------

\* No MS/MS information for FA composition.

marinedrugs-17-00533-t003_Table 3

###### 

Molecular species of glycolipids MGDG, MGMG, DGDG, and DGMG identified by HILIC-ESI-MS as \[M + NH4\]^+^ ions. C represents the total number of carbon atoms and N represents the total number of double bonds on the fatty acyl chains. The most abundant species in each class are highlighted in bold type. Fatty acids' *sn*-1 and *sn*-2 position is based on biosynthetic pathways \[[@B27-marinedrugs-17-00533],[@B28-marinedrugs-17-00533],[@B29-marinedrugs-17-00533]\].

  Theoretical *m/z*   Observed *m/z*   Error (ppm)   Lipid Species (C:N)   Fatty Acyl Chains   Formula
  ------------------- ---------------- ------------- --------------------- ------------------- ----------------------
  482.3329            482.3326         −0.62         MGMG(14:0)            14:0                C~23~H~48~NO~9~
  502.3016            502.3014         −0.40         MGMG(16:4)            16:4                C~25~H~44~NO~9~
  504.3173            504.3184         2.18          MGMG(16:3)            16:3                C~25~H~46~NO~9~
  506.3329            506.3331         0.39          MGMG(16:2)            16:2                C~25~H~48~NO~9~
  510.3642            510.3640         −0.39         MGMG(16:0)            16:0                C~25~H~52~NO~9~
  530.3329            530.3330         0.19          MGMG(18:4)            18:4                C~27~H~48~NO~9~
  536.3799            536.3799         0.00          MGMG(18:1)            18:1                C~27~H~54~NO~9~
  **556.3486**        **556.3485**     −**0.18**     **MGMG(20:5)**        **20:5**            **C~29~H~50~NO~9~**
  766.5469            766.5494         3.26          MGDG(34:5)            20:5/14:0           C~43~H~76~NO^10^
  774.6090            774.6104         1.81          MGDG(34:1)            18:1/16:0           C~43~H~84~NO~10~
  794.5782            794.5778         −0.50         MGDG(36:5)            20:5/16:0           C~45~H~80~NO~10~
  822.6095            822.6101         0.73          MGDG(38:5)            \*                  C~47~H~84~NO~10~
  **840.5626**        **840.5627**     **0.12**      **MGDG(40:10)**       **20:5/20:5**       **C~49~H~78~NO~10~**
  904.6878            904.6877         −0.11         MGDG(44:6)            \*                  C~53~H~94~NO~10~
  **672.4170**        **672.4172**     **0.30**      **DGMG(16:0)**        **16:0**            **C~31~H~62~NO~14~**
  698.4327            698.4326         −0.11         DGMG(18:1)            18:1                C~33~H~64~NO~14~
  718.4014            718.4015         0.14          DGMG(20:5)            20:5                C~35~H~60~NO~14~
  882.6154            882.6173         2.15          DGDG(30:0)            \*                  C~45~H~88~O~15~N
  906.6154            906.6166         1.32          DGDG(32:2)            \*                  C~47~H~88~O~15~N
  908.6310            908.6309         −0.11         DGDG(32:1)            18:1/14:0           C~47~H~90~O~15~N
  928.5997            928.5997         0.00          DGDG(34:5)            20:5/14:0           C~49~H~86~O~15~N
  932.6310            932.6319         0.97          DGDG(34:3)            \*                  C~49~H~90~O~15~N
  934.6467            934.645          −1.82         DGDG(34:2)            \*                  C~49~H~92~O~15~N
  936.6623            936.6623         0.00          DGDG(34:1)            18:1/16:0           C~49~H~94~O~15~N
  **956.6310**        **956.6317**     **0.73**      **DGDG(36:5)**        **20:5/16:0**       **C~51~H~90~O~15~N**
  984.6623            984.6617         −0.61         DGDG(38:5)            \*                  C~53~H~94~O~15~N
  1002.6154           1002.6160        0.60          DGDG(40:10)           20:5/20:5           C~55~H~88~O~15~N

\* No MS/MS information for FA composition.

marinedrugs-17-00533-t004_Table 4

###### 

Molecular species of phospholipids LPC, PC, LPE, and PE identified by HILIC-ESI-MS as positive \[M + H\]^+^ ions. C represents the total number of carbon atoms and N represents the total number of double bonds on the fatty acyl chains. The most abundant species in each class are highlighted in bold type. Fatty acids' *sn*-1 and *sn*-2 position is based on biosynthetic pathways \[[@B27-marinedrugs-17-00533],[@B28-marinedrugs-17-00533],[@B29-marinedrugs-17-00533]\].

  Theoretical *m/z*   Observed *m/z*   Error (ppm)   Lipid Species (C:N)   Fatty Acyl Chains         Formula
  ------------------- ---------------- ------------- --------------------- ------------------------- ----------------------
  468.3090            468.3092         0.43          LPC(14:0)             14:0                      C~22~H~47~NO~7~P
  494.3247            494.3242         −1.01         LPC(16:1)             16:1                      C~24~H~49~NO~7~P
  496.3403            496.3401         −0.40         LPC(16:0)             16:0                      C~24~H~51~NO~7~P
  516.3090            516.3090         0.00          LPC(18:4)             18:4                      C~26~H~47~NO~7~P
  518.3247            518.3236         −2.12         LPC(18:3)             18:3                      C~26~H~49~NO~7~P
  520.3403            520.3395         −1.54         LPC(18:2)             18:2                      C~26~H~51~NO~7~P
  522.3560            522.3564         0.77          LPC(18:1)             18:1                      C~26~H~53~NO~7~P
  **542.3247**        **542.3246**     −**0.18**     **LPC(20:5)**         **20:5**                  **C~28~H~49~NO~7~P**
  568.3403            568.3405         0.35          LPC(22:6)             22:6                      C~30~H~51~NO~7~P
  570.3560            570.3559         −0.18         LPC(22:5)             22:5                      C~30~H~53~NO~7~P
  706.5387            706.5387         0.00          PC(30:0)              14:0/16:0                 C~38~H~77~NO~8~P
  724.4917            724.4916         −0.14         PC(32:5)              \*                        C~40~H~71~NO~8~P
  726.5074            726.5070         −0.55         PC(32:4)              14:0/18:4                 C~40~H~73~NO~8~P
  728.5230            728.5233         0.41          PC(32:3)              14:0/18:3                 C~40~H~75~NO~8~P
  730.5387            730.5387         0.00          PC(32:2)              14:0/18:2 and 16:0/16:2   C~40~H~77~NO~8~P
  732.5543            732.5541         −0.27         PC(32:1)              16:0/16:1 and 14:0/18:1   C~40~H~79~NO~8~P
  734.5700            734.5696         −0.54         PC(32:0)              \*                        C~40~H~81~NO~8~P
  750.5074            750.5059         −2.00         PC(34:6)              \*                        C~42~H~73~NO~8~P
  752.5230            752.523          0.00          PC(34:5)              14:0/20:5                 C~42~H~75~NO~8~P
  754.5387            754.538          −0.93         PC(34:4)              16:0/18:4                 C~42~H~77~NO~8~P
  756.5543            756.5541         −0.26         PC(34:3)              16:0/18:3                 C~42~H~79~NO~8~P
  758.5700            758.5699         −0.13         PC(34:2)              16:0/18:2                 C~42~H~81~NO~8~P
  760.5856            760.5856         0.00          PC(34:1)              16:0/18:1                 C~42~H~83~NO~8~P
  774.5073            774.5058         −1.94         PC(36:8)              16:3/20:5                 C~44~H~73~NO~8~P
  776.5230            776.5215         −1.93         PC(36:7)              16:2/20:5                 C~44~H~75~NO~8~P
  778.5387            778.5386         −0.13         PC(36:6)              16:1/20:5                 C~44~H~77~NO~8~P
  780.5543            780.5544         0.13          PC(36:5)              16:0/20:5                 C~44~H~79~NO~8~P
  784.5856            784.5823         −4.21         PC(36:3)              \*                        C~44~H~83~NO~8~P
  786.6013            786.6002         −1.40         PC(36:2)              \*                        C~44~H~85~NO~8~P
  788.6169            788.6153         −2.03         PC(36:1)              14:0/22:1                 C~44~H~87~NO~8~P
  800.5230            800.5225         −0.62         PC(38:9)              18:4/20:5                 C~46~H~75~NO~8~P
  802.5387            802.5362         −3.12         PC(38:8)              18:3/20:5                 C~46~H~77~NO~8~P
  806.5700            806.5699         −0.12         PC(38:6)              18:1/20:5                 C~46~H~81~NO~8~P
  808.5856            808.5845         −1.36         PC(38:5)              18:0/20:5                 C~46~H~83~NO~8~P
  810.6013            810.597          −5.30         PC(38:4)              \*                        C~46~H~85~NO~8~P
  816.6482            816.6486         0.49          PC(38:1)              \*                        C~46~H~91~NO~8~P
  **826.5387**        **826.5391**     **0.48**      **PC(40:10)**         **20:5/20:5**             **C~48~H~77~NO~8~P**
  834.6013            834.5997         −1.92         PC(40:6)              20:1/20:5                 C~48~H~85~NO~8~P
  836.6169            836.6153         −1.91         PC(40:5)              \*                        C~48~H~87~NO~8~P
  854.5700            854.5696         −0.47         PC(42:10)             22:5/20:5                 C~50~H~81~NO~8~P
  862.6326            862.6334         0.93          PC(42:6)              22:1/20:5                 C~50~H~89~NO~8~P
  864.6482            864.6459         −2.66         PC(42:5)              22:0/20:5                 C~50~H~91~NO~8~P
  882.6013            882.6026         1.47          PC(44:10)             \*                        C~52~H~85~NO~8~P
  890.6639            890.6639         0.00          PC(44:6)              24:1/20:5                 C~52~H~93~NO~8~P
  480.3090            480.3092         0.42          LPE(18:1)             18:1                      C~23~H~47~NO~7~P
  **500.2777**        **500.2776**     −**0.20**     **LPE(20:5)**         **20:5**                  **C~25~H~43~NO~7~P**
  658.4448            658.4426         −3.34         PE(30:3)              \*                        C~35~H~65~NO~8~P
  688.4917            688.4936         2.76          PE(32:2)              16:1/16:1                 C~37~H~71~NO~8~P
  690.5074            690.5088         2.03          PE(32:1)              16:0/16:1 and 14:0/18:1   C~37~H~73~NO~8~P
  710.4761            710.4753         −1.13         PE(34:5)              14:0/20:5                 C~39~H~69~NO~8~P
  712.4917            712.4887         −4.21         PE(34:4)              16:0/18:4                 C~39~H~71~NO~8~P
  714.5074            714.5084         1.40          PE(34:3)              16:0/18:3 and 16:1/18:2   C~39~H~73~NO~8~P
  716.5230            716.5233         0.42          PE(34:2)              16:1/18:1 and 16:0/18:2   C~39~H~75~NO~8~P
  718.5387            718.5385         −0.28         PE(34:1)              16:0/18:1                 C~39~H~77~NO~8~P
  736.4917            736.4912         −0.68         PE(36:6)              \*                        C~41~H~71~NO~8~P
  738.5074            738.5073         −0.14         PE(36:5)              16:0/20:5                 C~41~H^73^NO~8~P
  742.5387            742.5381         −0.81         PE(36:3)              \*                        C~41~H~77~NO~8~P
  760.4917            760.489          −3.55         PE(38:8)              \*                        C~43~H~71~NO~8~P
  764.5230            764.5239         1.18          PE(38:6)              18:1/20:5                 C~43~H~75~NO~8~P
  766.5387            766.5396         1.17          PE(38:5)              16:0/22:5 and 18:0/20:5   C~43~H~77~NO~8~P
  **784.4917**        **784.492**      **0.38**      **PE(40:10)**         **20:5/20:5**             **C~45~H~71~NO~8~P**

\* No MS/MS information for FA composition.

marinedrugs-17-00533-t005_Table 5

###### 

Molecular species of phospholipids LPG, PG, PI, and PA identified by HILIC-ESI-MS as negative \[M − H\]^−^ ions. C represents the total number of carbon atoms and N represents the total number of double bonds on the fatty acyl chains. The most abundant species in each class are highlighted in bold type. Fatty acids' *sn*-1 and *sn*-2 position is based on biosynthetic pathways \[[@B27-marinedrugs-17-00533],[@B28-marinedrugs-17-00533],[@B29-marinedrugs-17-00533]\].

  Theoretical *m/z*   Observed *m/z*   Error (ppm)   Lipid Species (C:N)   Fatty Acyl Chains         Formula
  ------------------- ---------------- ------------- --------------------- ------------------------- ----------------------
  **455.2410**        **455.2425**     **3.29**      **LPG(14:0)**         **14:0**                  **C~20~H~40~O~9~P**
  481.2566            481.258          2.91          LPG(16:1)             16:1                      C~22~H~42~O~9~P
  483.2723            483.2741         3.72          LPG(16:0)             16:0                      C~22~H~44~O~9~P
  529.2566            529.2583         3.21          LPG(20:5)             20:5                      C~26~H~42~O~9~P
  691.4550            691.4565         2.17          PG(30:1)              14:0/16:1                 C~36~H~68~O~10~P
  693.4707            693.4724         2.45          PG(30:0)              14:0/16:0                 C~36~H~70~O~10~P
  719.4863            719.4879         2.22          PG(32:1)              14:0/18:1 and 16:0/16:1   C~38~H~72~O~10~P
  721.502             721.5039         2.63          PG(32:0)              16:0/16:0 and 14:0/18:0   C~38~H~74~O~10~P
  739.455             739.4583         4.46          PG(34:5)              14:0/20:5                 C~40~H~68~O~10~P
  745.502             745.5033         1.74          PG(34:2)              16:0/18:2 and 16:1/18:1   C^40^H~74~O~10~P
  747.5176            747.5189         1.74          PG(34:1)              16:0/18:1 and 14:0/20:1   C~40~H~76~O~10~P
  749.5333            749.5345         1.60          PG(34:0)              16:0/18:0 and 14:0/20:0   C~40~H~78~O~10~P
  **765.4707**        **765.4735**     **3.66**      **PG(36:6)**          **16:1/20:5**             **C~40~H~70~O~10~P**
  767.4863            767.4871         1.04          PG(36:5)              \*                        C~42~H~72~O~10~P
  773.5333            773.5348         1.94          PG(36:2)              18:1/18:1                 C~42~H~78~O~10~P
  775.5489            775.5508         2.45          PG(36:1)              14:0/22:1                 C~42~H~80~O~10~P
  777.5646            777.5662         2.06          PG(36:0)              \*                        C~42~H~82~O~10~P
  783.4812            783.4810         −0.29         PG(36:5-OH)           16:0-OH/20:5              C~42~H~72~O~11~P
  801.5646            801.5668         2.74          PG(38:2)              16:0/24:2                 C~44~H~82~O~10~P
  805.5959            805.5945         −1.74         PG(38:0)              \*                        C~44~H~86~O~10~P
  813.4707            813.4736         3.60          PG(40:10)             20:5/20:5                 C~46~H~70~O~10~P
  829.5959            829.599          3.74          PG(40:2)              16:1/24:1 and 14:0/26:2   C~46~H~86~O~10~P
  831.6115            831.6138         2.77          PG(40:1)              14:0/26:1                 C~46~H~88~O~10~P
  859.6428            859.6452         2.79          PG(42:1)              16:0/26:1                 C~48~H~92~O~10~P
  855.5024            855.5039         1.75          PI(36:5)              16:0/20:5                 C~45~H~76~O~13~P
  881.5180            881.5204         2.72          PI(38:6)              18:1/20:5                 C~47~H~78~O~13~P
  **901.4867**        **901.4888**     **2.33**      **PI(40:10)**         **20:5/20:5**             **C~49~H~74~O~13~P**
  965.6119            965.6138         1.97          PI(44:6)              \*                        C~53~H~90~O~13~P
  **739.4339**        **739.4346**     **0.95**      **PA(40:10)**         **20:5/20:5**             **C~43~H~64~O~8~P**
  743.4652            743.4669         2.29          PA(40:8)              20:4/20:4                 C~43~H~68~O~8~P

\* No MS/MS information for FA composition.
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###### 

Molecular species of IPC identified by HILIC-ESI-MS as negative \[M + CH~3~COO\]^−^ ions. C represents the total number of carbon atoms and N represents the total number of double bonds on the fatty acyl chains. The most abundant species are highlighted in bold type.

  Theoretical *m/z*   Observed *m/z*   Error (ppm)   Lipid Species (C:N)   Fatty Acyl Chains   Formula
  ------------------- ---------------- ------------- --------------------- ------------------- -----------------------
  892.5915            892.5933         2.02          PI-Cer(d38:2)         \*                  C~46~H~87~NO~13~P
  918.6072            918.6096         2.61          PI-Cer(d40:3)         \*                  C~48~H~89~NO~13~P
  **920.6228**        **920.6217**     **−1.19**     **PI-Cer(d40:2)**     \*                  **C~48~H~91~NO~13~P**
  922.6385            922.6353         −3.47         PI-Cer(d40:1)         \*                  C~48~H~93~NO~13~P
  946.6385            946.6403         1.90          PI-Cer(d42:3)         \*                  C~50~H~93~NO~13~P
  948.6541            948.6535         −0.63         PI-Cer(d42:2)         \*                  C~50~H~95~NO~13~P

\* No MS/MS information for FA composition.
